Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 29% ± 13% | |
| endothelial cell | 3 studies | 25% ± 8% | |
| fibroblast | 3 studies | 24% ± 9% | |
| ciliated cell | 3 studies | 26% ± 3% | |
| natural killer cell | 3 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 1117.47 | 89 / 89 | 100% | 12.03 | 901 / 901 |
| thymus | 100% | 1093.40 | 653 / 653 | 100% | 13.75 | 605 / 605 |
| uterus | 100% | 1436.29 | 170 / 170 | 100% | 12.63 | 459 / 459 |
| breast | 100% | 1202.54 | 459 / 459 | 100% | 11.77 | 1117 / 1118 |
| brain | 100% | 1533.03 | 2639 / 2642 | 100% | 18.07 | 705 / 705 |
| intestine | 100% | 1208.04 | 966 / 966 | 100% | 9.47 | 526 / 527 |
| prostate | 100% | 1073.33 | 245 / 245 | 100% | 12.16 | 501 / 502 |
| ovary | 100% | 1062.81 | 180 / 180 | 100% | 8.44 | 429 / 430 |
| lung | 100% | 935.72 | 576 / 578 | 100% | 10.05 | 1155 / 1155 |
| stomach | 100% | 829.84 | 359 / 359 | 100% | 8.90 | 285 / 286 |
| adrenal gland | 100% | 1504.60 | 258 / 258 | 100% | 19.30 | 229 / 230 |
| esophagus | 100% | 1113.43 | 1445 / 1445 | 99% | 8.75 | 182 / 183 |
| bladder | 100% | 1316.76 | 21 / 21 | 99% | 10.59 | 501 / 504 |
| skin | 100% | 1107.93 | 1808 / 1809 | 99% | 12.02 | 468 / 472 |
| liver | 100% | 656.20 | 226 / 226 | 99% | 7.48 | 402 / 406 |
| pancreas | 98% | 456.74 | 321 / 328 | 100% | 10.77 | 178 / 178 |
| adipose | 100% | 1231.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1745.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.31 | 29 / 29 |
| spleen | 100% | 785.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.32 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.35 | 1 / 1 |
| muscle | 100% | 1096.92 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 1215.82 | 847 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 8.14 | 75 / 80 |
| peripheral blood | 67% | 324.12 | 620 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0033615 | Biological process | mitochondrial proton-transporting ATP synthase complex assembly |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TMEM242 |
| Protein name | Transmembrane protein 242 |
| Synonyms | C6orf35 BM-033 HSPC287 |
| Description | FUNCTION: Scaffold protein that participates in the c-ring assembly of mitochondrial ATP synthase (F(1)F(0) ATP synthase or complex V) by facilitating the membrane insertion and oligomer formation of the subunit c/ATP5MC3 . Participates in the incorporation of the c-ring into vestigial complexes . Additionally influences the incorporation of subunits MT-ATP6, MT-ATP8, ATP5MJ, and ATP5MK in the ATP synthase . . |
| Accessions | Q5T2S1 Q9NWH2 ENST00000367144.4 ENST00000400788.9 |
